HQLライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (2 5月 2024 @ 03:38):

Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe...

Stats
本日の出来高	35 266.00
平均出来高	99 631.00
時価総額	362.12M
次の収益日	( $0 ) 2024-06-03
Last Dividend	$0.300 ( 2023-11-21 )
Next Dividend	$0 ( N/A )
P/E	16.76
ATR14	$0.0100 (0.08%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-30	Saba Capital Management, L.p.	Buy	16 573	Common Stock
2024-04-26	Saba Capital Management, L.p.	Buy	120 304	Common Stock
2024-04-25	Saba Capital Management, L.p.	Buy	97 574	Common Stock
2024-04-24	Saba Capital Management, L.p.	Buy	20 529	Common Stock
2024-04-23	Saba Capital Management, L.p.	Buy	48 203	Common Stock

INSIDER POWER
100.00
Last 58 transactions
Buy: 554 423 \| Sell: 55 759

ボリューム相関

長: 0.09 (neutral)

短: -0.99 (very strong negative)

Signal:(60.54) Neutral

Tekla Life Sciences 相関

10 最も正の相関
FPI	0.888
TSN	0.883
ASH	0.878
DHX	0.878
AMRC	0.874
DVN	0.873
CWT	0.871
PDS	0.868
CVX	0.867
EBR-B	0.864

10 最も負の相関
VCRA	-0.862
AMAM	-0.861
COR	-0.86
SCX	-0.856
IOT	-0.853
NGL	-0.845
FPAC-UN	-0.845
MOG-B	-0.842
TNK	-0.835
TK	-0.831

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Tekla Life Sciences 相関 - 通貨/商品

0.35
( neutral )

0.29
( neutral )

0.00
( neutral )

0.03
( neutral )

-0.09
( neutral )

Tekla Life Sciences 財務諸表

Annual	2023
収益:	$23.52M
総利益:	$18.28M (77.71 %)
EPS:	$0.830

FY	2023
収益:	$23.52M
総利益:	$18.28M (77.71 %)
EPS:	$0.830

FY	2022
収益:	$-103.25M
総利益:	$-108.80M (105.37 %)
EPS:	$-4.07

FY	2021
収益:	$65.69M
総利益:	$0.00 (0.00 %)
EPS:	$2.78

Financial Reports:

No articles found.

Tekla Life Sciences Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.310 (N/A)	$0.310 (N/A)	$0.330 (N/A)	$0.320 (N/A)	$0.320 (N/A)	$0.300 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Tekla Life Sciences Dividend Information - Dividend King

Dividend Sustainability Score: 1.232 - low (50.00%) | Divividend Growth Potential Score: 1.007 - No dividend expected

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$1.640	1996-11-14
Last Dividend	$0.300	2023-11-21
Next Dividend	$0	N/A
Payout Date	2024-01-10
Next Payout Date	N/A
# dividends	99	--
Total Paid Out	$43.17	--
Avg. Dividend % Per Year	5.54%	--
Score	5.04	--
Div. Sustainability Score	1.232
Div.Growth Potential Score	1.007
Div. Directional Score	1.119	--

Next Divdend (Est)
(2024-05-06)

$0.326 Estimate 38.53 %

Dividend Stability

0.77 Good

Dividend Score

5.04

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
1996	$1.640	10.80%
1997	$0.740	5.38%
1998	$0.360	2.76%
1999	$1.110	9.06%
2000	$4.16	20.50%
2001	$3.14	14.90%
2002	$2.18	10.20%
2003	$1.240	10.10%
2004	$1.365	8.62%
2005	$2.06	13.00%
2006	$1.240	7.90%
2007	$1.170	8.74%
2008	$1.100	8.33%
2009	$0.420	4.59%
2010	$0.520	5.46%
2011	$1.010	9.29%
2012	$1.160	10.00%
2013	$1.390	9.19%
2014	$1.770	8.72%
2015	$2.80	11.20%
2016	$2.07	8.99%
2017	$1.620	9.38%
2018	$1.620	8.18%
2019	$1.400	9.03%
2020	$1.560	8.98%
2021	$1.690	8.71%
2022	$1.360	7.05%
2023	$1.270	8.87%
2024	$0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
KIO	Dividend Royal	2023-12-14	Monthly	12	7.05%	8.50
NCZ	Dividend Royal	2024-02-09	Monthly	22	7.79%	8.50
SCM	Dividend King	2023-12-15	Monthly	13	7.08%	8.50
SJT	Dividend Royal	2023-11-29	Monthly	39	12.52%	8.50
GOF	Dividend Royal	2023-11-14	Monthly	18	8.03%	8.50
SRV	Dividend Royal	2023-12-04	Monthly	18	7.53%	8.50
VGI	Dividend Royal	2024-02-09	Monthly	13	7.36%	8.50
JQC	Dividend Royal	2023-11-14	Monthly	22	6.56%	8.50
PHK	Dividend Royal	2023-11-10	Monthly	22	6.88%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.568	1.500	10.00	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0556	1.200	8.15	9.78	[0 - 0.3]
returnOnEquityTTM	0.0813	1.500	-0.207	-0.311	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	0.0000000	2.00	0.0000000	0.0000000	[0 - 30]
freeCashFlowPerShareTTM	0.0000000	2.00	0.0000000	0.0000000	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.867	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	0.568	1.000	0.649	0.649	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0.0978	0.800	-2.68	-2.14	[0.5 - 2]
Total Score				1.232

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	15.67	1.000	8.52	0	[1 - 100]
returnOnEquityTTM	0.0813	2.50	-0.133	-0.311	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.0000000	2.00	0.0000000	0.0000000	[0 - 30]
dividendYielPercentageTTM	10.17	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.0000000	2.00	0.0000000	0.0000000	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.0619	1.500	-3.75	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0000000	1.000	-2.50	0	[0.1 - 0.5]
Total Score				1.007

Tekla Life Sciences

Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. It was formerly known as H&Q Life Sciences Investors fund. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.